The formation of β-amyloid deposits is considered a histopathological feature of Alzheimer´s disease (AD). In vivo molecular imaging by means of amyloid-avid radiotracers will allow for an early and conclusive diagnostic of AD. Herein, we describe the radiosynthesis of the radiofluorinated styryl benzoxazole derivative 
The in vivo biological evaluation of [
18 F]-1 showed that this new radiotracer has a moderate brain uptake with a slow brain washout and a poor in vivo stability
Highlights
• Design of a fluorinated styryl benzoxazole derivative for detection of β-amyloid plaques.
• Nucleophilic radiofluorination with readily available [ 18 F]KF.
• Metabolism and biodistribution studies of the radiofluorinated styryl benzoxazole derivative.
Introduction
Progressive neurodegenerative disorders such as Alzheimer´s (AD) or Parkinson´s (PD) disease affect millions of persons worldwide and pose a significant impact in public health, especially as more people approach old age. These diseases, known as "protein misfolding diseases" are characterized by the accumulation of insoluble protein deposits like β-amyloid (Aβ), neurofibrillar tangles in AD, and alpha-synuclein (αSyn) in PD. The molecular processes underlying these diseases are still not completely understood, but the deposition of the amyloid deposits is considered an early and specific event in their pathogenesis (Bacskai, Hickey et al. 2003; Irvine, El-Agnaf et al. 2008 ).
Being available suitable probes for in vivo targeting of Aβ deposits, the use of molecular imaging modalities is expected to demonstrate the locations and densities of such deposits in the AD brain allowing an early and assertive diagnosis of AD and/or the monitoring of anti-amyloidogenic therapies. Among the available molecular imaging modalities, positron emission tomography (PET) is the best suited to achieve such goal, particularly based on amyloid-avid molecules radiolabelled with the cyclotron produced radionuclides carbon-11 ( 11 C) and fluorine-18 ( 18 F) (Kung 2012; Lee, Choe et al. 2012; Ribeiro Morais, Paulo et al. 2012) .
A good performing PET radiotracer for in vivo imaging of amyloid deposits must show a high binding affinity to Aβ and a good permeability through the blood brain barrier (BBB), with minimal non-specific retention in the brain. F-labeled compounds ( Fig. 1) (Liu, Kepe et al. 2007; Choi, Golding et al. 2009; Jureus, Swahn et al. 2010; Vandenberghe, Van Laere et al. 2010; Barthel, Gertz et al. 2011; Clark, Schneider et al. 2011 
Experimental Section

Chemistry
The tosylated precursor 2-[N-methyl-N-(2`-tosyloxyethyl)-4`-aminostyryl]benzoxazole in benzene (25 mL) was reacted with K t BuO (525 mg, 4.7 mmol) at rt. After 3 h, the reaction mixture was diluted with EtOAc (100 mL) and was extracted with water (100 mL). The organic phase was dried over MgSO 4 , filtered and the filtrate was dried under vacuum. Then, the resulting phosphorane was refluxed overnight with N-methyl-N-(2-tosyloxyethyl)-4 aminobenzaldehyde (590 mg, 1.8 mmol) in anhydrous THF (25 mL).
Thereafter, the solvent was concentrated and the reaction crude was re-dissolved in CH 2 Cl 2 (100 mL). The organic phase was extracted with sat. sol. of NaHCO 3 (100 mL).
The organic extract was dried over MgSO 4 , filtered and the filtrate was concentrated.
Compound 3 (550 mg, 65 %) was purified by column column chromatography on silica gel (n-hexane/EtOAc/CHCl 3 3:1:1). To a solution of 3 (250 mg, 0.55 mmol) in anhydrous THF (23 mL) was added anhydrous TBAF (1.8 mL, 1.8 mmol, 1.0 M in THF). The reaction mixture was refluxed for 30 minutes. Thereafter the solvent was concentrated; chloroform (50 mL) was added to the residue and was extracted with sat sol NaHCO 3 (50 mL). The organic phase was dried over MgSO 4 , filtered and the filtrate was concentrated. Column chromatographic on silica gel (n-hexane/EtOAc 4:1) gave the mixture of 1-Z and 1-E (124 mg, 76%). in a conical glass vial. The vial was sealed and heated for 20 min at 90°C in an oil bath.
Radiochemistry
After cooling the mixture was subjected to semi-preparative HPLC (Discovery C18, 4.6
x 250 mm, 5µm, Supelco) using isocratic elution with acetonitrile/0.1%TFA (70/30) at a flow rate of 4 mL/min originated by a PU1580 pump (Jasco). The products were monitored by UV detector (UV2075, Jasco) at 254nm and by gamma-detection with a scintillation detector (Nuclear Interface).
The radiolabeled product [ 18 F]-1 eluting at 9-10 min was separated, diluted with 30mL of water and the whole solution was subjected to a C18 cartridge (200 mg. LiChrolut).
The cartridge was washed with 5 mL of water, after that the radiolabeled product Lichrograph® system (Merck-Hitachi) equipped with a L4500 UV detector, a L6200 pump and a scintillation detector Gabi (Raytest) using a C18 column (Luna C18(2), 4.6x250, 5µm) and the indicated isocratic eluent with a flow rate of 1.0 mL/min. and a specific activity 7-28 GBq/µmol at end of synthesis.
Metabolite analysis
Male Wistar-Unilever rats (n = 2; body weight 150 ± 12 g) were anesthetized with desflurane (9-10% v/v, 30% oxygen/air). The threshold value for breathing frequency was 65 breaths/min. Animals were put in supine position and placed on a heating pad to maintain body temperature. The spontaneously breathing rats were heparinized with 100 units/kg heparin (Heparin-Natrium 25.000-ratiopharm ® , ratiopharm GmbH, Germany)
by subcutaneous injection to prevent blood clotting on intravascular catheters. After local anesthesia with lignocain (1%; Xylocitin ® loc, mibe, Jena, Germany) into the right groin, a catheter (0.8 mm Umbilical Vessel Catheter, Tyco Healthcare, Tullamore, Ireland) was introduced into the right femoral artery for arterial blood sampling. A second needle catheter (35 G) was placed into a tail vein and was used for [ 18 F]-1 radiotracer injection (39 MBq in 0.5 mL of E153/10% ethanol, infusion 1 mL/min).
Arterial blood samples were taken 1.5, 10, 30 and 60 min after injection. Arterial plasma was separated by centrifugation (11.000g x 3min) followed by precipitation of the proteins with methanol (2 volumes to 1 volume plasma) followed by 5 min storage at -60°C. The clear supernatant separated by centrifugation was used for analysis. The radio-HPLC system (Agilent 1100 series) applied for metabolite analysis was equipped with UV detection (254 nm) and an external radiochemical detector (RAMONA, Raytest GmbH, Straubenhardt, Germany). Analysis was performed on a Zorbax C18 300SB (250 × 9.4 mm; 4 µm) column with an eluent system A (water + 0.1%TFA) and B (acetonitrile + 0.1% TFA) in the following gradient: 5 min 95% A, 10 min to 95% B, 5 min at 95% B and 5 min to 95%A at a flow rate of 3 mL/min.
Biodistribution studies in Wistar rats
The animal research committee of the Regierungspräsidium Dresden approved the animal facilities and the experiments according to institutional guidelines and the for a group of animals.
Results and Discussion
Recently, we have introduced new fluorinated styryl benzoxazole (compound 1) and styryl benzothiazole (compound 2) derivatives that were synthesized based on a multistep and convergent approach, using the Wittig reaction as a key step to introduce the styryl moiety (Scheme 1) (Ribeiro Morais, Miranda et al. 2011) . Compounds 1 and 2 were obtained as mixtures of geometric E and Z isomers, being the E isomer formed preferably in spite of the Z/E photoisomerization ability of these compounds. The assessment of the in vitro binding affinity of the E and Z isomers of 1 and 2 towards different types of amyloid fibrils (insulin, α-synuclein and β−amyloid peptide) has shown that compound 1 displays the highest Aβ binding affinity and selectivity. These studies have also proved that the Z/E geometric isomerism has almost no influence on the binding profile of 1 and 2 (Ribeiro Morais, Miranda et al. 2011) . Altogether, these data led us to consider 1 the most promising compound to be further evaluated as an This combination catalyst, commonly used in radiofluorination reaction, increases the solubility of the fluoride ion and enhances its nucleophilicity (Liu, Zhu et al. 2010 decay-corrected radiochemical yield and high radiochemical purity (> 99%, both isomers) with a specific activity of 7-28 GBq/µmol at end of synthesis. The radiotracer (Fig. 3) , indicating the ocurrence of in vivo defluorination. In vivo defluorination has been recently reported for related 18 F-labeled styryltriazole derivatives carrying also the radioactive label at an aliphatic sp3 carbon atom (Lee, Choe et al. 2012) . Table 1 . Biodistribution results of • Nucleophilic radiofluorination with readily available [ • Metabolism and biodistribution studies of the radiofluorinated styryl benzoxazole derivative.
